Movicol (Polyethylene Glycol/PEG 3350) Safety in Pregnancy
Polyethylene glycol-based laxatives like Movicol are safe to use during pregnancy and represent a first-line treatment option for constipation in pregnant women. 1
Safety Profile
PEG 3350 is not systemically absorbed and passes through the gastrointestinal tract unchanged, bound to water molecules, without affecting maternal or fetal physiology 2
The medication does not cause significant absorption or loss of water or electrolytes, and does not affect the colonic mucosa 2
Macrogol (PEG) can be safely used throughout all trimesters of pregnancy, including the first trimester, as it lacks systemic absorption and has no teratogenic concerns 3, 2
Clinical Recommendation
The 2024 AGA guidelines explicitly recommend polyethylene glycol-based laxatives as a safe treatment option for constipation during pregnancy. 1
First-Line Treatment Approach:
Start with dietary modifications: increase fiber intake to approximately 30 g/day through fruits, vegetables, whole grains, and legumes 1
Ensure adequate fluid intake, particularly water, to soften stools 1
If dietary measures are insufficient, initiate PEG 3350 (Movicol) as first-line pharmacologic therapy 1, 3
Advantages Over Alternatives:
PEG 3350 offers faster onset of bowel action compared to lactulose 3
Causes fewer flatulences than lactulose, improving maternal comfort 3
Can be used long-term without safety concerns, unlike stimulant laxatives which should be avoided due to conflicting safety data 1
Dosing
Standard adult dosing of PEG 3350 is 17 g once daily 4
Important Caveats
Avoid stimulant laxatives during pregnancy as safety data are conflicting and they may cause tenesmus associated with preterm birth risk 1, 3
Excessive use of osmotic laxatives can cause maternal bloating, though this is not a safety concern 1
Bulk-forming agents (psyllium, methylcellulose) are also safe alternatives due to lack of systemic absorption 1